, Politico Influence
White & Case will represent state-owned Russian bank
Charles Duan

From Politico Influence:

The coalition describes its mission as “fighting abuses of the patent system that can extend government-granted monopolies that illegitimately keep drug prices high…

, Menafn
USPTO Director and Leading IP Experts to Share Insights at IAM’s Patent Litigation 2019
Charles Duan

From Menafn:

The panels include big names in the world of IP, such as:

Charles Duan, Director, Technology and Innovation Policy, R Street Institute

, Fenwick & West
Still No Shortage of Viewpoints as Eligibility Debate Moves to the Hill
Charles Duan

From Fenwick & West: 

After Director Kappos came the first testimony critical of the draft legislation, from Charles Duan, director of technology and innovation policy at the R Street…

, Foley & Lardner LLP
The State of Patent Eligibility – Report on Senate Hearings
Charles Duan

From Foley & Lardner LLP:

Charles Duan, director of technology and innovation and a senior fellow at the R Street Institute, testified that the draft legislation would go too far in permitting…

Letter to the Senate Subcommittee on Intellectual Property on Pharmaceutical Competition and Patents
Charles Duan

June 11, 2019

The Honorable Thom Tillis
 Subcommittee on Intellectual Property
 Committee on the Judiciary
 U.S. Senate
 224 Dirksen Senate Office…

Testimony Before the U.S. Senate Subcommittee on Patents on Patent Eligibility
Charles Duan


Chairman Tillis, Ranking Member Coons, and Members of the Subcommittee:

Thank you for…

, The ASHG Blog
ASHG, AMP, and Partner Groups Oppose New Bill Allowing Gene Patenting
Charles Duan

From The ASHG Blog:

In his testimony, Charles Duan, Director of Technology and Innovation Policy at the R Street Institute, disagreed with Senator Coons’ claims, citing that the draft bill…

, Wired
Congress is Debating—Again—Whether Genes Can be Patented
Charles Duan

From Wired:

Even witnesses at Tuesday’s hearings had differing interpretations of the bill’s language. Charles Duan, a patent policy researcher at the R Street Institute in Washington, DC,…

, Science Magazine
Controversial U.S. bill would lift Supreme Court ban on patenting human genes
Charles Duan

From Science Magazine:

But the witnesses at the hearing had different interpretations of the bill’s text. The intent to preserveMyriad is “inconsistent with the legislative text that’s…

, Politico eHealth
On tap today: More gene patenting debate
Charles Duan

From Politico eHealth:

Critics weren’t convinced. Charles Duan of the R Street Institute — which co-signed ACLU’s letter — testified that Coons’ claim was “inconsistent with the…